Results 111 to 120 of about 14,956 (188)

Brief Report: Dolutegravir-Based Therapy, Diet, Physical Activity, and Weight Gain: A 48-week Prospective Cohort in South Africa. [PDF]

J Acquir Immune Defic Syndr
Tien D, Chandiwana N, Shazi G, Chen G, Mabweazara S, Moosa MS, Gupta RK, Pillay D, Marconi VC, Hedt-Gauthier B, Venter WDF, Siedner MJ, McCluskey SM, Manne-Goehler J.   +13 more
europepmc   +1 more source

Real-world efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in HR+/HER2 - metastatic breast cancer: a single-institution experience. [PDF]

J Egypt Natl Canc Inst
Hussein NE, Gad AM, AbdAllah A, El Baghdady NS.   +3 more
europepmc   +1 more source

Synthesis of 1-substituted-4-[4-(1H-indol-3-yl)butyl]piperazines

ARKIVOC, 2013
Linas Labanauskas, Rita Mazeikaite, Gintaras Urbelis, Olga Gedrimaite, Jurgis Sudzius, Inga Cikotiene   +5 more
doaj   +1 more source

Recent Advances in Dopamine Receptor Ligands as Chemical Biology Tools. [PDF]

ACS Omega
Dorogan M, Namballa HK, Patra S, Harding WW.   +3 more
europepmc   +1 more source

Programmable Piperazine Synthesis via Organic Photoredox Catalysis. [PDF]

J Am Chem Soc
Boley AJ, Genova JC, Nicewicz DA.
europepmc   +1 more source

Kidney abnormalities in young people living with HIV on dolutegravir-based regimens in Kampala, Uganda. [PDF]

AIDS Res Ther
Nasuuna EM, Hoffman R, Kalyesubula R, Chikwari CD, Weiss HA.   +4 more
europepmc   +1 more source

Detection of Signals for Smell and Taste Disorders Associated with Z-drugs: A Disproportionality Analysis of the FAERS Database. [PDF]

Oral Health Prev Dent
Yang H, Liang Y, Wang H, Xu Q, Kou Z, Zou Y.   +5 more
europepmc   +1 more source

Challenges in Achieving Viral Suppression Among Adolescents and Young Adults Under a Dolutegravir-Based Regimen: Living with HIV in Gabon. [PDF]

Pathogens
Bivigou-Mboumba B, Moussavou-Boundzanga P, Akombi FL, Eyi Zang C, Bouassa-Bouassa AF, Luzolo S, Okome P, Mouinga-Ondeme A, Ategbo S.   +8 more
europepmc   +1 more source

Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment. [PDF]

J Antimicrob Chemother
Beca LSDAB, Mumbiro V, Bwakura M, Mujuru HA, Mudzingwa S, Tagarro A, Domínguez-Rodríguez S, Musiime V, Nalwanga D, Buck WC, Sacarlal J, Chabala C, Chansa BN, Rojo P, Burger DM, Moraleda C, Jacobs TG, EMPIRICAL Clinical Trial Group .   +17 more
europepmc   +1 more source

Computational Approach to Select Lead-Like Compounds From an Opioid Class of Novel Psychoactive Substances. [PDF]

Chem Biodivers
Arsić B, Micić R, Kostić E, Micić A, Lukić V.   +4 more
europepmc   +1 more source